Literature DB >> 8684189

Heparin prophylaxis in bedridden patients.

J F Bergmann, C Caulin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684189     DOI: 10.1016/s0140-6736(05)66160-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Fatal pulmonary embolism in hospitalised medical patients.

Authors:  T P Baglin; K White; A Charles
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

2.  Effect of medical thromboprophylaxis on mortality from pulmonary embolus and major bleedingy.

Authors:  J Alasdair Millar
Journal:  Australas Med J       Date:  2015-09-30

Review 3.  Prevention of venous thromboembolism in medically ill patients: a clinical update.

Authors:  Alexander G G Turpie; Alain Leizorovicz
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

4.  Evaluation of the efficacy of venous thromboembolism prophylaxis guideline implementation in Japan.

Authors:  Kiyoaki Niimi; Masayoshi Kobayashi; Hiroshi Narita; Kiyohito Yamamoto; Kimihiro Komori
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

5.  Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study.

Authors:  I Mahé; J F Bergmann; P d'Azémar; J J Vaissie; C Caulin
Journal:  Eur J Clin Pharmacol       Date:  2005-06-25       Impact factor: 2.953

6.  Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatients.

Authors:  José Labarère; Jean-Luc Bosson; Jean-François Bergmann; Nathalie Thilly
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

Review 7.  Diet as prophylaxis and treatment for venous thromboembolism?

Authors:  David K Cundiff; Paul S Agutter; P Colm Malone; John C Pezzullo
Journal:  Theor Biol Med Model       Date:  2010-08-11       Impact factor: 2.432

8.  An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients.

Authors:  Meyer Michel Samama; Franz-Xaver Kleber
Journal:  Thromb J       Date:  2006-07-03

Review 9.  Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).

Authors:  Raza Alikhan; Rachel Bedenis; Alexander T Cohen
Journal:  Cochrane Database Syst Rev       Date:  2014-05-07

Review 10.  Primary prevention of venous thromboembolism in elderly medical patients.

Authors:  Karine Lacut; Gregoire Le Gal; Dominique Mottier
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.